The study examined Streptococcus pneumoniae in China, where pneumococcal conjugate vaccine (PCV) coverage is low and antibiotic use high. Researchers analysed genomes of 2,841 isolates from 29 provinces, collected 2008 to 2025, against global genomes. One lineage, Global Pneumococcal Sequence Cluster 1, dominated and drove penicillin non-susceptibility, while two serotype 3 lineages expanded. Predicted resistance to at least one class was 98.87%, including 97.18% to macrolide-lincosamide-streptogramin B antibiotics and 97.15% to tetracycline. Estimated serotype coverage was 72.69% for PCV13, 73.39% for PCV15 and 78.35% for PCV20. Resistance was predicted from genes and random forest modelling rather than measured by laboratory testing.
Why it is interesting: China's pneumococcal genomes differ markedly from those in countries with routine PCV programmes. Predicted resistance is near-universal, yet existing vaccines still cover most circulating serotypes.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.